Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration

A retrospective chart review of patients with persistent subretinal and/or intraretinal fluid, despite previous treatment with intravitreal ranibizumab (0.5 mg), who were switched to aflibercept injections, was performed. Treatment was three monthly aflibercept (2 mg) injections followed by dosing o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gharbiya, Magda, Iannetti, Ludovico, Parisi, Francesco, De Vico, Umberto, Mungo, Maria Laura, Marenco, Marco
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2014
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4033502/
https://ncbi.nlm.nih.gov/pubmed/24895562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/273754
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi